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Purpose/Objective: For several years evidence is 
accumulating that not only the more eminent known nuclear 
DNA mutations but also different variations (e.g. deletions 
and mutations) in the mitochondrial DNA (mtDNA) are 
associated with a wide variety of cancers. Unlike nuclear DNA 
(nDNA), mtDNA is polyploid, only maternally inherited and is 
encoding for 13 subunits of the oxidative phosphorylation 
(OXPHOS) machinery responsible for aerobic ATP production. 
Several mutations and variations in genes involved in OXPHOS 
are associated with a decreased ATP production and 
increased oxidative stress. Current study aimed at 
characterizing proliferation, metabolism and intrinsic 
radiosensitivity in ρ0 cells, cell lines depleted from their 
mtDNA. We hypothesized that ρ0 cells have a pronounced 
glycolytic profile resulting in radiosensitization compared to 
their parental counterparts. 
Materials and Methods: ρ0 cells were generated by depleting 
BEAS-2B (lung/bronchus epithelial) immortalized cells or 
A549 (lung adenocarcinoma) and 143B (osteosarcoma) tumor 
cell lines from their mtDNA by adding ethidium bromide (50 
ng/ml) to the culture media for several weeks. mtDNA copy 
number was checked by qPCR. Proliferation was assessed 
using the IncuCyte FLR and metabolic profiles (mitochondrial 
and glycolysis stress test) were generated using the Seahorse 
XF96. Radiosensitivity was investigated by performing 
clonogenic survival assays after exposing cells to different 
irradiation doses. 
Results: For the parental cell lines, the A549 cells had a 
higher mitochondrial ATP production, less spare OXPHOS 
capacity and more proton leak. 143B were more dependent 
on glucose metabolism and had the lowest glycolytic reserve 
capacity. The BEAS-2B cells showed an intermediate result 
for both assays. Different characteristics of a ρ0 cell are 
changed compared to its parental cell. All ρ0 cell lines 
showed reduced mitochondrial respiration, whereas 
increased glycolysis was observed with a lack of glycolytic 
reserve compared to the parental lines. The ρ0 phenotype 
also resulted in a decreased proliferative capacity of these 
cells. Dose response curves showed that BEAS-2B ρ0 cells 
were more radioresistant (p<0.0001) while 143B ρ0 showed a 
more radiosensitive phenotype compared to the parental 
counterparts (p<0.0007). For the A549 cells no differences 
were found for radiosensitivity between parental and ρ0 cell 
lines. 
Conclusions: These findings suggest that different types of ρ0 
react differently upon irradiation. It has been suggested that 
the capacity to cope with metabolic stress determines the 
radiosensitivity of tumor cells and might be correlated to the 
metabolic profile of the parental cells. Therefore, we are 
currently investigating if varying ROS levels or basal ATP 
production of the cells drives these differences in 
radiosensitivity by e.g. influencing antioxidant defenses and 
if known OXPHOS inhibitors (e.g. rotenone, metformin) could 
potentially demonstrate the same effects.  
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Purpose/Objective: Respiration-induced tumor motion is an 
important source of geometric uncertainty in radiotherapy 
for (gastro-) esophageal cancer. However, it is difficult to 
quantify this motion particularly in the cranio-caudal (CC) 
direction due to the limited soft tissue contrast on CT. In this 
study, we aimed at quantifying esophageal tumor motion 
relative to the bony anatomy using markers and 4DCT data.  
Materials and Methods: Eighteen esophageal cancer patients 
underwent endoscopy-guided implantation of in total 65 
markers, of 3 different types, at the cranial border, caudal 
border, and/or the center of the primary tumor. A 4DCT scan 
was acquired after marker implantation for all patients. 
Table 1 gives an overview of patient and marker 
characteristics. The 4DCT scans were reconstructed and 
sorted into 10 phases throughout a breathing cycle. 
Retrospectively, for each patient, the 1st phase (0%, the end 
of inhale) in the 4DCT was selected as the reference to which 
the 9 remaining phases were rigidly registered based on the 
vertebra. Then, markers were manually identified and 
classified into 3 groups based on their positions in the 
esophagus as measured from the incisors: proximal, mid and 
distal esophagus. Next, individual marker displacements in 
each phase relative to the reference positions were assessed 
in the left-right (LR), CC, anterior-posterior (AP) directions, 
and vector distance (3D). 
Results: In total, 56 markers could be identified: 3, 13 and 40 
markers in the proximal, mid, and distal esophagus, 
respectively (Table 1, Figure 1). Different types of markers 
showed no difference in visibility on 4DCT. Figure 1 shows the 
mean and standard deviation (SD) of the marker 
displacements relative to the reference in each breathing 
phase. Also the distribution of the maximum difference in 
marker position over the course of one breathing cycle in the 
LR, CC, and AP directions as well as in 3D is shown. For all 56 
markers, the maximum difference in position (mean ± SD) 
was 3.0 ± 2.1, 6.0 ± 2.8, and 3.4 ± 2.0 mm in the LR, CC, and 
AP directions, respectively. Overall, displacements were 
significantly larger in the CC than in the LR and AP directions 
(p<0.05, Wilcoxon signed-rank test). However, for all 4 
distally located markers in patient 13 distinct larger 
displacements in the LR than in the CC and AP directions 
were observed. Moreover, the 3D maximum difference in 
marker position was 2.9 ± 1.1 in the proximal, 3.6 ± 1.8 in 
the mid, and 8.6 ± 2.4 mm in the distal esophagus. In all 3 
directions and in 3D, displacements of markers located in the 
distal esophagus were significantly larger than of markers in 
the proximal and mid esophagus (p<0.05, Wilcoxon rank-sum 
test).
Conclusions: Generally, respiration-induced motion is largest 
in the CC direction. However, the motion in the LR and 
AP directions cannot be neglected when the tumor is 
located in the distal esophagus. Hence, with clearly visible 
markers on 4DCT, the respiration-induced motion could be 
incorporated to individualize the safety margin, by for 
instance using an internal target volume, mid-ventilation, 
or breath-control technique.  
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Purpose/Objective: In our institute, cervical cancer patients 
are treated with a library-based Plan-of-the-Day (PotD) 
protocol. In this protocol an in-room Cone Beam CT (CBCT) 
scan acquired just before dose delivery is used to select the 
treatment plan that is best fitting the observed anatomy. 
However, treatment accuracy may be compromised by shape 
and position changes of the cervix-uterus resulting from 
intra-fractional filling of the bladder and rectum, and by 
intra-fraction variations in patient setup. The purpose of this 
study is to quantify these uncertainties using pre- and post-
fraction acquired CBCT scans. 
Materials and Methods: Intra-fraction uncertainties were 
evaluated for 16 cervical cancer patients with a tip-of-uterus 
displacement larger than 2.5 cm as measured in an empty 
and full bladder planning CT scan. The treatment protocol 
includes a post-fraction CBCT to verify target coverage after 
dose delivery. In 316 pre- and post-fraction CBCT scans, the 
bladder, cervix-uterus, and rectum were delineated and 
volume changes in bladder and rectum filling were 
calculated. The pre- and post-fraction CBCT scans were 
aligned to the bony anatomy to quantify intra-fraction 
patient setup motion. To quantify intra-fraction 
displacements of the cervix-uterus, an in-house developed 
point-based non-rigid registration method was used to non-
rigidly align the pre-fraction target shape to the post-fraction 
one (Fig. 1a). The intra-fraction distances were projected on 
the average cervix-uterus shape obtained by the non-rigid 
registration. Finally, intra-fraction cervix-uterus motion was 
correlated to volume differences in bladder. 
Results: The mean time between the pre- and post-fraction 
CBCT scans was 20.8±3.2 minutes (1SD). Bladder volume 
increased on average by 62±55 ml over all treatment 
fractions and rectum volume increased on average 4.6±32.8 
ml. Table 1 summarizes the overall mean, systematic and 
random error for the intra-fraction patient setup motion, and 
the mean, SD, and 95th percentile for the intra-fraction 
cervix-uterus motion. Figure 1b shows for one patient a color 
representation of the treatment-averaged intra-fraction 
distances projected on the patient’s average cervix-uterus 
shape. The population-mean intra-fraction cervix-uterus 
displacements were 3.0±1.4, 4.7±2.8, and 3.4±2.1 mm 
projected on the LR, CC, and AP axis, respectively. There 
was a significant correlation between bladder inflow rate and 
cervix-uterus motion (R=0.6 and p<0.01). 
 
 
 
 
 
Conclusions: Intra-fraction patient setup motion was small. 
Intra-fraction motion of the cervix-uterus was considerably 
larger and should not be ignored in the design of PotD 
strategies. For example, the results of this study can be used 
